Navigation Links
Chiltern Expands European Operations With a New Office in Belgium
Date:6/17/2009

LONDON, June 17 /PRNewswire/ -- Chiltern, a leading global clinical research organization, announced that it has opened a new office in Brussels and is pleased to have appointed Mr. Maurizio Passinisi as our new country manager for Belgium and The Netherlands.

Mr. Maurizio Passanisi received a Master of Science degree in Industrial Engineering from the Institut Superieur Industriel Liegeois of Liege (ISIL) in 1993 and a Master of Science degree in Management from Haute Ecole Commerciale (HEC) - University of Liege in 2008. Mr. Passanisi has over 15 years of experience working in both Pharmaceutical and Clinical Research areas.

"Belgium and The Netherlands have always been attractive locations to conduct clinical trials," Maurizio commented. "The quality of the research is outstanding. Belgium and The Netherlands have many key opinion leaders (KOL) involved in clinical research lending additional weight to the data and keeping these countries at the forefront of modern research."

"Chiltern is experiencing healthy growth despite the current economic climate," explained Lewis Cameron, Executive Vice President for Europe. "Chiltern is continuing its growth in Europe and will shortly announce further expansion in Eastern Europe. Our primary goal is to deliver expert, high quality services around the world and these actions demonstrate our commitment to regional expansion in order to serve our clients needs globally."

Company profile

About Chiltern:

Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad range of therapeutic areas for a wide variety of clients. Chiltern has conducted trials in more than 40 countries and employs 1400 staff across 29 countries. Chiltern provides services including Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. Further information is available at www.chiltern.com.

    For More Information Contact:

    Stuart McGuire                            Mac McElroy
    Chiltern International Ltd.               Chiltern International Inc.
    171 Bath Road                             1241 Volunteer Parkway
    Slough                                    Suite 950
    Berkshire SL1 4AA                         Bristol, TN 37620
    UNITED KINGDOM                            USA
    Tel:  +44 (0) 1753 512 000                Tel:  +1 (423) 968 9533
    Fax: +44 (0) 1753 511 116                 Fax: +1 (423) 968 3567
    Email: stuart.mcguire@chiltern.com        Email: mac.mcelroy@chiltern.com


'/>"/>
SOURCE Chiltern International Limited
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Marco Romano, MD Joins Chiltern as Medical Director, Europe
2. Chiltern Appoints Steve Albrecht to Support Further Expansion in Late Phase
3. Chiltern Announces Acquisition of an Independent USA Based Clinical Research Organization, Clinical Trial Management Services, Inc.
4. Chiltern to Participate at the Partnerships in Clinical Trials Conference in Amsterdam
5. Diana Hatsis of Chiltern Will Present at the Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO) 35th Annual Continuing Education Program Held in Conjunction With the American Academy of Ophthalmology (AAO) Annual Meeting
6. Chiltern Announced Today That it has Acquired the Business of Drug Development Solutions (DDS)
7. Chiltern Wins Top Prize
8. Chiltern Will Sponsor and Present at the 17th Annual Partnerships With CROs Meeting in Las Vegas, April 14 - 16, 2008.
9. Chiltern Opens a New Office in Russia
10. Chiltern Announces New Expansion in Portugal
11. Chiltern Expands Its Global Reach to Latin America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... ... at the 2016 Anti-Aging & Beauty Awards at The Aesthetic & Anti-aging ... Anti-aging Medicine European Congress (AMEC) brings together the industry’s leading scientific experts, ...
(Date:12/5/2016)... Columbus, OH (PRWEB) , ... December 05, 2016 ... ... novel engineering solution called the CardioQuick Patch® significantly improves the reproducibility and accuracy ... usability in various healthcare settings. , Over the last 60 years, studies ...
(Date:12/4/2016)... York, NY (PRWEB) , ... December 03, 2016 ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – hosted its first Swirl: A Wine Tasting Event in New York ...
(Date:12/4/2016)... ... December 03, 2016 , ... While James Earl Jones is known ... for in a show called "Front Page". One of the forthcoming episodes examines mammogram ... rates have plummeted in large part due to early detection. Like any other disease, ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... Entrepreneurial Company in the Dallas area” Tuesday evening at the 26th Annual SMU ... presented by SMU's Cox School’s Caruth Institute for Entrepreneurship. Dallas 100™, co-founded by ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... 2016   Pairnomix, LLC, a genetic research company ... by the White House, today announced that findings from its ... of candidate therapies for a patient with epileptic encephalopathy caused ... presented at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process ...
(Date:12/4/2016)... , Dec. 3, 2016  Findings from ... safety of CTL019, an investigational chimeric antigen receptor ... pediatric and young adult patients with B-cell acute ... an oral session at the 58th American Society ... 3, 4:00-5:30 p.m.). The global Phase II study ...
(Date:12/2/2016)... British Columbia , December 2, 2016 bioLytical Laboratories, ... de la Compañía, el INSTI HIV Self Test , a los miembros ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) ...
Breaking Medicine Technology: